Latest News for: drug-induced lupus erythematosus

Edit

Global Systemic Lupus Erythematosus Drugs Market is on track to experience a significant boost, reaching an astonishing US$ 329.18 Billion by 2032

Pharmiweb 21 Feb 2024
Systemic Lupus Erythematosus Drugs Market ... It is also called as drug-induced lupus erythematosus due to common observation against drugs such as isoniazid, hydralazine and procainamide ... Systemic Lupus Erythematous (SLE) Drugs Market.
Edit

Global Systemic Lupus Erythematous Drugs Industry Set to Surge, Projected to Reach US$ 329.18 Billion by 2032

Pharmiweb 20 Nov 2023
Systemic Lupus Erythematous Drugs Industry ... It is also called as drug-induced lupus erythematosus due to common observation against drugs such as isoniazid, hydralazine and procainamide ... Systemic Lupus Erythematous (SLE) Drugs Market.
Edit

Lupus Disease Statistics worldwide: Drug Development, Clinical Trials, and Market Access | Disease Landscape Insights

Longview News-Journal 11 Sep 2023
There are several types of Lupus Disease with systemic lupus erythematosus (SLE) being the most common one ... Drug-Induced Lupus- This type of lupus occurs due to the side effect of certain medications.
Edit

Lupus Therapeutic Market to Grasp Outstanding Growth of USD 5,142.63 Million by 2029

Pharmiweb 19 Jul 2023
Data Bridge Market Research recently revealed a comprehensive market intelligence study on the Lupus Therapeutic Market ... Type Systemic Lupus Erythematosus (SLE) Cutaneous Lupus Erythematosus, Drug-Induced Lupus Erythematosus Neonatal Lupus.
Edit

Systemic Lupus Erythematous SLE Drugs Market to reach a valuation of US$ 329.18 Billion by 2032

Pharmiweb 16 Mar 2023
It is also called as drug-induced lupus erythematosus due to common observation against drugs such as isoniazid, hydralazine and procainamide.
  • 1

Most Viewed

×